BridgeMD
New treatment option for Candida
Official title Candida PCR Diagnosis Strategy in Patients From Intensive Care Units
ClinicalTrials.gov ID: NCT04874441
What this study is testing
- What it's testing
- The aim of this study is to evaluate the implementation of a new technique for invasive candidiasis diagnosis by PCR. The main objective will be to evaluate the effect of this strategy on the time required to obtain results in patients from intensive care units with suspected systemic invasive candidiasis.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient affiliated or benefiting from a social protection system
- Patient (or his/her trusted person) having given free and informed written consent to the investigating physician
- Non-neutropenic patient hospitalised in the Toulouse University Hospital intensive care unit.
- Patient with suspected invasive candidiasis for whom a blood culture for fungal infection diagnosis was taken and for whom an empirical treatment...
You likely can't join if
- Patients under guardianship or trusteeship, persons under court protection
- Pregnant or breastfeeding patients.
The study team makes the final eligibility decision.
Where it's taking place
- Toulouse, Occitanie, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toulouse, Occitanie, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.